Behavioral mechanisms underlying inhibition of food-maintained responding by the cannabinoid receptor antagonist/inverse agonist SR141716A

Author： De Vry J. Schreiber R. Eckel G. Jentzsch K.R.

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.483, Iss.1, 2004-01, pp. : 55-63

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

SR141716A is an inverse agonist at the human cannabinoid CB 1 receptor

By Landsman R.S. Burkey T.H. Consroe P. Roeske W.R. Yamamura H.I.

European Journal of Pharmacology, Vol. 334, Iss. 1, 1997-09 ,pp. : 1-2

Elsevier

Access to resources Recommend Favorite

The cannabinoid receptor antagonist SR-141716 does not readily antagonize open-field effects induced by the cannabinoid receptor agonist (R)-methanandamide in rats

By Jarbe T.U.C. DiPatrizio N.V. Li C. Makriyannis A.

Pharmacology Biochemistry and Behavior, Vol. 75, Iss. 4, 2003-07 ,pp. : 809-821

Elsevier

Access to resources Recommend Favorite

Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A

By Aceto M.D. Scates S.M. Lowe J.A. Martin B.R.

European Journal of Pharmacology, Vol. 282, Iss. 1, 1995-08 ,pp. : 1-2

Elsevier

Access to resources Recommend Favorite

Effects of the cannabinoid receptor antagonist SR 141716, alone and in combination with dexfenfluramine or naloxone, on food intake in rats

By Rowland Neil Mukherjee Monica Robertson Kimberly

Psychopharmacology, Vol. 159, Iss. 1, 2001-12 ,pp. : 111-116

Springer Publishing Company

Access to resources Recommend Favorite

SR 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice

By Richardson J.D. Aanonsen L. Hargreaves K.M.

European Journal of Pharmacology, Vol. 319, Iss. 2, 1997-01 ,pp. : 3-4

Elsevier

Access to resources Recommend Favorite